Get started
Author

Rishu Agarwal

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
2018 · Constantine S. Tam, Mary Ann Anderson, et al. · New England Journal of Medicine · 431
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
2018 · Rishu Agarwal, Yih-Chih Chan, et al. · Nature Medicine · 205
Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia
2017 · Paul Yeh, Tane Hunter, et al. · Nature Communications · 93
PDF
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
2020 · Prasath Pararajalingam, Krysta M. Coyle, et al. · Blood · 71
PDF
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes
2017 · Paul Yeh, Michael Dickinson, et al. · Blood · 59
Role of immunohistochemistry in the era of genetic testing in MYC -positive aggressive B-cell lymphomas: a study of 209 cases
2015 · Rishu Agarwal, Stephen Lade, et al. · Journal of Clinical Pathology · 35
Three Year Update of the Phase II ABT-199 (Venetoclax) and Ibrutinib in Mantle Cell Lymphoma (AIM) Study
2019 · Sasanka M. Handunnetti, Mary Ann Anderson, et al. · Blood · 34
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions
2024 · Sasanka M. Handunnetti, Mary Ann Anderson, et al. · Blood · 25
PDF
Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory
2017 · Rishu Agarwal, Piers Blombery, et al. · Annals of Hematology · 22
Understanding resistance mechanisms to BTK and BCL2 inhibitors in mantle cell lymphoma: implications for design of clinical trials
2018 · Rishu Agarwal, Mark A. Dawson, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 18
Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1st FLOR' Study
2019 · Allison Barraclough, Geoff Chong, et al. · Blood · 13
Synchronous Presentation of Multiple Myeloma and Lung Cancer
2008 · Rishu Agarwal, Ritu Gupta, et al. · Journal of Clinical Oncology · 12
PDF
Combination ibrutinib (Ibr) and venetoclax (Ven) for the treatment of mantle cell lymphoma (MCL): Primary endpoint assessment of the phase 2 AIM study.
2017 · Constantine Si Lun Tam, Andrew Warwick Roberts, et al. · Journal of Clinical Oncology · 8
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement
2022 · Anoop K. Enjeti, Rishu Agarwal, et al. · Pathology · 7
PDF
Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome
2021 · Charlotte F.M. Hughes, Paolo Gallipoli, et al. · Pathology · 7
Immune priming with nivolumab followed by nivolumab and rituximab in first-line treatment of follicular lymphoma: The phase 2 1st FLOR study.
2021 · Eliza Anne Hawkes, Sze Ting Lee, et al. · Journal of Clinical Oncology · 6
A Window Study of Acalabrutinib & Rituximab, Followed By Chemotherapy & Autograft (ASCT) in Fit Patients with Treatment Naïve Mantle Cell Lymphoma (MCL): First Report of the Investigator-Initiated Australasian Leukaemia & Lymphoma Group NHL33 ‘Wamm’ Trial
2023 · Eliza A Hawkes, Sze Ting Lee, et al. · Blood · 5
Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology
2024 · Stephen B. Ma, Wendi Lin, et al. · Pathology · 4
KITD816V mutation detection: a comparative study using peripheral blood, bone marrow aspirate and bone marrow trephine samples for detection ofKITmutations in patients with systemic mastocytosis
2013 · Rishu Agarwal, Michelle McBean, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Pitfalls in the diagnosis of haematological malignancies
2013 · Rishu Agarwal, Surender Juneja · New Zealand journal of medical laboratory science · 4
Combination Ibrutinib (ibr) and Venetoclax (ven) for the Treatment of Mantle Cell Lymphoma (mcl): Primary Endpoint Assessment of the Phase 2 Aim Study
2017 · C.S. Tam, A.W. Roberts, et al. · Hematological Oncology · 3
PDF
Diagnostic and Follow-up Eosinophilia Is Not Predictive of Outcome in Childhood Acute Myeloid Leukemia
2011 · Rishu Agarwal, Sreenivas Vishnubhatla, et al. · Journal of Pediatric Hematology/Oncology · 3
Unusual cytochemical reactivity for toluidine blue in granular acute lymphoblastic leukemia: a report of two rare cases.
2010 · Rishu Agarwal, Ritu Gupta, et al. · PubMed · 1
Validation of a next-generation sequencing-based RNA fusion panel for haematological malignancies in a tertiary care hospital
2026 · Philip Qian, Wendi Lin, et al. · Pathology
Ultrasensitive next-generation sequencing-based clonality assay for disease monitoring in B-cell acute lymphoblastic leukaemia
2026 · Anita Le, Wendi Lin, et al. · Pathology
Works count: 32
Citation count: 1,070
H-index: 12
I10-index: 12
Year
Topic
Type